<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01935596</url>
  </required_header>
  <id_info>
    <org_study_id>PI09-PR-DUPONT</org_study_id>
    <nct_id>NCT01935596</nct_id>
  </id_info>
  <brief_title>Comparative Study of the Effects of Two Local Anesthetics Administered Intrathecally: 0.5% Levobupivacaine and Ropivacaine 0.5%</brief_title>
  <acronym>ROPI-LEVO</acronym>
  <official_title>Comparative Study of the Effects of Two Local Anesthetics Administered Intrathecally: 0.5% Levobupivacaine and Ropivacaine 0.5%</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Biomedical Research, prospective, randomized, double blind, controlled monocentric,&#xD;
      phase IV comparison of the effects of two local anesthetics intrathecally: 0.5%&#xD;
      levobupivacaine and ropivacaine 0.5%.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Progress in the practice of anesthesia led to a safety requirement of growing in daily&#xD;
      practice. Spinal anesthesia commonly used technique for surgery of the lower limbs, provides&#xD;
      a triple neurological lock (sensory, motor and autonomic) of roots of the spinal cord by&#xD;
      intrathecal injection of a local anesthetic agent, following the rules of and strict aseptic&#xD;
      conditions.&#xD;
&#xD;
      Levobupivacaine and ropivacaine local anesthetic agents are considered less toxic and tend to&#xD;
      replace the use of bupivacaine, reference molecule, but the plasma transition is extremely&#xD;
      toxic to patients. However, there is currently no study comparing the benefits of&#xD;
      levobupivacaine and ropivacaine in isobaric form injected intrathecally for trauma surgery of&#xD;
      the lower limbs. We propose to conduct a prospective, randomized double-blind comparison of&#xD;
      the use of these two molecules in spinal isobaric form by evaluating the time and duration of&#xD;
      action (sensory and motor block), hemodynamic and ventilatory changes (sympathetic block),&#xD;
      and the occurrence of any adverse events.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>duration of anesthesia on sensitivity</measure>
    <time_frame>during 6h after induction</time_frame>
    <description>Thermo-algesic exploration of sensitivity through the application of an ice cube</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of anesthesia on motor block</measure>
    <time_frame>during 6h after induction</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Patients Undergoing Lower Limb Surgery</condition>
  <arm_group>
    <arm_group_label>ropivacaïne 0,5%,</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intrathecal administration of 15mg of ropivacaine 0.5%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lévobupivacaïne 0,5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intrathecal administration of 15mg of levobupivacaine 0.5%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaïne</intervention_name>
    <description>spinal anesthesia.</description>
    <arm_group_label>ropivacaïne 0,5%,</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lévobupivacaïne</intervention_name>
    <arm_group_label>lévobupivacaïne 0,5%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient admitted to the emergency for lower limb trauma,&#xD;
&#xD;
          -  age over 18 years and below 65 years&#xD;
&#xD;
          -  lower limb trauma surgery can be performed under spinal anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal of patients to participate in the study,&#xD;
&#xD;
          -  Patient with cons-indication to spinal anesthesia:&#xD;
&#xD;
               -  Local anesthetic allergy agents (1/13000)&#xD;
&#xD;
               -  bleeding disorders, including pharmacological origin&#xD;
&#xD;
               -  infection at the puncture site,&#xD;
&#xD;
               -  refusal of spinal anesthesia by the patient,&#xD;
&#xD;
          -  Patient trust,&#xD;
&#xD;
          -  Patients whose coagulation is abnormal.&#xD;
&#xD;
          -  Patients with cognitive impairment or incapacitated adult,&#xD;
&#xD;
          -  Multiple trauma,&#xD;
&#xD;
          -  Porphyria,&#xD;
&#xD;
          -  Central preexisting neuropathy,&#xD;
&#xD;
          -  A history of spinal surgery,&#xD;
&#xD;
          -  Epilepsy uncontrolled by treatment,&#xD;
&#xD;
          -  Hypovolemia,&#xD;
&#xD;
          -  Pregnant or lactating women,&#xD;
&#xD;
          -  Participation in another ongoing clinical trial,&#xD;
&#xD;
          -  Patient on anticoagulant therapy,&#xD;
&#xD;
          -  Patient not affiliated with a social security system.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hervé DUPONT, Professor</last_name>
    <role>Study Director</role>
    <affiliation>CHU Amiens France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hervé DUPONT</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <study_first_submitted>August 23, 2012</study_first_submitted>
  <study_first_submitted_qc>September 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2013</study_first_posted>
  <last_update_submitted>May 13, 2016</last_update_submitted>
  <last_update_submitted_qc>May 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anesthesia</keyword>
  <keyword>Randomized study</keyword>
  <keyword>Lower limbs surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

